SEC Form 4 · accession 0001209191-16-150817
XBiotech Inc. · XBIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Queena Han
Officer — VP Finance & HR
Period of report
Nov 15, 2016
Accepted (ET)
Nov 17, 2016 · 4:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001626878
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Nov 15, 2016 | M | 19,573 | $0.74 | A | 19,573 | D | |
| Common Stock | Nov 15, 2016 | S | 19,573 | $15.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock options | $0.74 | Sep 8, 2016 | M | 19,573 | D | Dec 10, 2007 | Dec 9, 2016 | Common Stocks | 19,573 | 0 | D |
Remarks
The stock option exercise price was CAD$1.00, which is equivalent to USD $0.74 as of the date of the transaction. This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person on September 30, 2016 for exercise of stock options expiring in December 2016.